Source: Annual Congress 2009 - Pressure for plasticity: the pulmonary interstitium in the diseased lung



Rating:

Share or cite this content

Citations should be made in the following way:
P. Rocco (Rio De Janeiro, Brazil). The role of glycosaminoglycans in respiratory disease. Annual Congress 2009 - Pressure for plasticity: the pulmonary interstitium in the diseased lung

Member's Comments

No comment yet.

Related content which might interest you: The role of chronic infection in respiratory diseases Source: International Congress 2018 – Chinese Programme 2018: Part I Year: 2018 Platelets: a potential role in chronic respiratory diseases? Source: Eur Respir Rev, 30 (161) 210062; 10.1183/16000617.0062-2021 Year: 2021 The role of disbalance in the system of neutrophil/elastase and alpha1-antiprotease in the course of respiratory infectious process in CF Source: Eur Respir J 2001; 18: Suppl. 33, 125s Year: 2001 Investigating the role of smoking in the development of aspirin-exacerbated respiratory disease Source: International Congress 2018 – Variant forms of asthma Year: 2018 The role of surfactant on chronic infant lung disease Source: Annual Congress 2003 - Chronic infant lung disease Year: 2003 The role of respiratory viruses in etiological structure of exacerbation of chronic and recurrent lung diseases in children Source: Eur Respir J 2007; 30: Suppl. 51, 391s Year: 2007 Diaphragm dysfunction in chronic obstructive pulmonary disease: a role for heparan sulphate? Source: Eur Respir J 2007; 30: 80-89 Year: 2007 The lung microbiome in obstructive airways disease: potential pathogenetic roles Source: Eur Respir Monogr 2019; 83: 140-157 Year: 2019 The role of inflammation in chronic heart failure Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 The role of viruses in the pathogenesis of pulmonary fibrosis Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease Year: 2021 The role of infection in the development of chronic lung disease of prematurity Source: Annual Congress 2007 - Chronic lung disease of prematurity: pathogenesis and outcomes Year: 2007 The microbiome in chronic respiratory diseases Source: International Congress 2017 – Can we translate the microbiome from basic science to clinical practice? Year: 2017 Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure Source: Eur Respir Rev, 30 (162) 210077; 10.1183/16000617.0077-2021 Year: 2021 Autopsy-proven pulmonary determinants in patients with acute respiratory failure Source: Annual Congress 2010 - Intensive care unit outcome Year: 2010 The role of calcium metabolism assessment in the clinical setting of interstitial lung diseases Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021 Relation between respiratory diseases and the development of cardiovascular events in patients with respiratory viral infection Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020